Annika Dejmek
Titel
Universitetslektor/Överläkare
Organisation
+4640331488
Annika [dot] Dejmek [at] med [dot] lu [dot] se
Publikationer (hämtat ur Lunds universitets publikationsdatabas)
författare
- 2013
- 2010
- 2008
- 2007
- Comparison of NCL-hTERT antibody reactivity and telomere repeat amplification protocol in situ in effusions
- Comparison of NCL-hTERT antibody reactivity and telomere repeat amplification protocol in situ in effusions.
- Lower proliferation rate in metastatic effusion mesothelial cells than in benign effusions.
- Napsin A (TA02) is a useful alternative to thyroid transcription factor-1 (TTF-1) for the identification of pulmonary adenocarcinoma cells in pleural effusions
- No detection of SV40 DNA in mesothelioma tissues from a high incidence area in Sweden.
- The proliferation rates in mesothelial cells in effusions also containing metastatic cells are lower than in benign effusions
- Weak telomerase activity in malignant cells in metastatic serous effusions - Correlation to short survival time
- Weak telomerase activity in malignant cells in metastatic serous effusions correlates to short survival time.
- 2006
- 2005
- Telomere repeat amplification protocol (TRAP in situ reveals telomerase activity in three cell types in effusions: malignant cells, proliferative mesothelial cells, and lymphocytes
- The combination of CEA, EMA, and BerEp4 and hyaluronan analysis specifically identifies 79% of all histologically verified mesotheliomas causing an effusion.
- Wnt-5a protein expression in primary dukes B colon cancers identifies a subgroup of patients with good prognosis.
- 2003
